BEONE MEDICINES LTD-ADR
ONCNASDAQ🏆 #347 by market capEarnings Nov 5US Equity
$358.74▼ $0.54 (−0.15%)
Live1h▲ 0.1%
24h▼ 0.1%
7d▲ 9.6%
14d▲ 9.7%
30d▲ 18.1%
1y▲ 24.5%
🏦Market Cap
$38.33B
Mid Cap
📈Revenue Growth (YoY)
+40.2%
High Growth
📊Gross Margin
87.8%
High
💵FCF Margin
21.4%
Strong
⚖️P/S Ratio
7.4x
Fair
Otter Score
50
Weak
📊
Analyst Ratings
Price
$358.74
Total
14
Raised
1
Lowered
0
Avg PT
$400.67
H / L
$451 / $367
| Institution | Action | Rating | Date |
|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-08-06 |
Barclays | Reiterated | Overweight | 2026-08-06 |
Citizens | Reiterated | Market Outperform | 2026-08-06 |
JP Morgan | Reiterated | Overweight | 2026-07-23 |
Jefferies | Upgraded | Hold → Buy | 2026-07-13 |
Truist Securities | Reiterated | Buy | 2026-07-07 |
RBC Capital | Reiterated | Outperform | 2026-07-07 |
Leerink Partners | Reiterated | Outperform | 2026-05-15 |
Citigroup | Reiterated | Buy | 2025-11-10 |
Morgan Stanley | Reiterated | Overweight | 2025-10-20 |
TD Securities | Reiterated | Buy | 2025-04-24 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-28 |
Macquarie | Reiterated | Outperform | 2025-02-28 |
TD Cowen | Reiterated | Buy | 2024-11-13 |
One row per institution, most recent rating